Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-16

FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ScieGen Pharmaceuticals' original application for Metformin Hydrochloride Extended-Release Tablets, a generic metformin product for type 2 diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metformin Hydrochloride Extended-release Tablets (metformin hydrochloride extended-release)

Snippet

ORIG AP for METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS)